Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Schering-Plough acquires exclusive worldwide rights to oral ribavirin for HCV

July 20, 1998

Solvay describes motilin agonists related to erythromycin

July 20, 1998

One-year trial shows efficacy of lamivudine for treatment for chronic hepatitis B

July 20, 1998

ICN develops compound for treatment of NSAID-induced ulcers

July 16, 1998

Schering-Plough, Immune Response collaborate to develop hepatitis gene therapy

July 16, 1998

Orally active gastric antisecretory agents synthesized and evaluated at Daiichi

July 15, 1998

Sanwa Kagaku selects optically active candidate gastric prokinetic agent

July 14, 1998

Vertex describes new protease inhibitors as therapeutics for HCV

July 14, 1998

L-Ornithine-L-aspartate: safe treatment for cirrhosis and chronic hepatic encephalopathy

July 13, 1998

Korean investigators design effective and safe agents for HBV

July 10, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...